Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ProtoKinetix Inc PKTX

Healthcare Biotechnology
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions... see more

Recent & Breaking News (OTCQB:PKTX)

Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery

Business Wire October 17, 2017

ProtoKinetix and Proactive Immune Sciences Announce a Joint Research Collaboration Using AAGP™ in Immune Cell Cryopreservation Testing

Business Wire June 5, 2017

ProtoKinetix Completes First Year of Trials on Retinal Replacement Therapy Using AAGP™

Business Wire May 24, 2017

ProtoKinetix Announces Start of Phase 1 & Phase 2 Clinical Trials for the use of AAGP™ PKX-001 Treated Islet Cells in the Treatment of Type 1 Diabetes

Business Wire March 9, 2017

ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration

Business Wire February 7, 2017

ProtoKinetix Announces Investigator Sponsored Human Clinical Trial Application Using AAGP™ Has Been Approved by Health Canada

Business Wire January 24, 2017

ProtoKinetix, Incorporated Announces Investigator Sponsored Clinical Trial Submitted to Health Canada for the use of AAGP™ in the Treatment of Type 1 Diabetes

Business Wire January 17, 2017

ProtoKinetix’ 2nd Quarter Scientific Update

Business Wire July 14, 2016

ProtoKinetix Completes Non-Brokered Private Placement & Secures Operating Line of Credit

Business Wire June 16, 2016

ProtoKinetix’ AAGP™ has been Published in the Journal of Tissue Engineering and Regenerative Medicine

Business Wire June 7, 2016

ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP™

Business Wire May 12, 2016

AAGP™ Improves Results in Stem Cells Transplanted in Retina Tissue by 300%

Business Wire May 2, 2016

ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP(TM)

Business Wire April 26, 2016

ProtoKinetix Corporate Update

Business Wire January 5, 2016

AAGP(TM) Found to Significantly Improve Islet Cell Transplantation in Type 1 Diabetes Patients

Business Wire December 17, 2015

ProtoKinetix Completes Private Placement

Business Wire November 9, 2015

ProtoKinetix Begins Testing Diabetic Mice with AAGP(TM) at the University of Alberta

Business Wire September 18, 2015

ProtoKinetix' AAGP(TM) to Be Presented at the Congress of the International Pancreas and Islet Transplant Association

Business Wire September 10, 2015

ProtoKinetix Reports on Its Strong Collaboration with the James Shapiro Laboratory at the University of Alberta

Business Wire August 4, 2015

ProtoKinetix Announces Appointment of New Director and Provides Corporate Update

Business Wire July 1, 2015